RapidAI (formerly iSchemaView) develops an enterprise clinical AI platform that analyzes CT and MRI scans to support diagnostic and treatment decisions for stroke, aneurysm, pulmonary embolism, and other vascular conditions. Its Rapid Enterprise Platform integrates deep imaging AI into hospital workflows and is backed by 750+ peer-reviewed studies.